Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

REGENXBIO Inc. RGNX

Set alert

Price alert · RGNX

All alert types
7.16 USD -0.04 -0.56%

At close · Nov 2

7.16 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
7.16 × 2
Ask
7.17 × 2
7.04 Day range 7.46
5.65 52-week range 15.98
YTD
-50.28%
1 year
-43.93%
Open
7.27
Prev close
7.20
Mkt cap
472.65M
Vol
1.03M
Avg vol
1.36M
EPS
-3.76
P/E
0.00
Div yield
0.00%
More statistics
Low
7.04
High
7.46
Forward P/E
-6.83
Beta
1.23
Short ratio
6.02
Inst. own
92.34%
Dividend
0.00
Ex-div date
50-d avg
9.58
200-d avg
13.24
1y target
37.64

5D chart

Chart tools
Interval
1m5m15m30m

Signals (90)
NameTimeAgo
MACD: Sell SignalNov 2, 4:00 PM11 hours ago
SMA: BearishNov 2, 3:55 PM11 hours ago
RSI: OverboughtNov 2, 3:45 PM11 hours ago
SMA: BullishNov 2, 2:35 PM12 hours ago
SMA: BullishNov 2, 2:35 PM12 hours ago
SMA: BearishNov 2, 2:30 PM12 hours ago
MACD: Buy SignalNov 2, 2:00 PM13 hours ago
MACD: Sell SignalNov 2, 1:30 PM13 hours ago
SMA: BearishNov 2, 1:10 PM14 hours ago
SMA: BullishNov 2, 1:05 PM14 hours ago
MACD: Buy SignalNov 2, 1:05 PM14 hours ago
SMA: BullishNov 2, 12:55 PM14 hours ago
MACD: Sell SignalNov 2, 12:20 PM15 hours ago
MACD: Buy SignalNov 2, 11:50 AM15 hours ago
SMA: BullishNov 2, 11:30 AM15 hours ago
SMA: BearishNov 2, 10:50 AM16 hours ago
MACD: Sell SignalNov 2, 10:40 AM16 hours ago
SMA: BearishNov 2, 10:30 AM16 hours ago
SMA: BullishNov 2, 10:20 AM17 hours ago
SMA: BearishNov 2, 10:15 AM17 hours ago

Newest 20 of 90.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 37.64 +425.6% upside
Target (low)
22.00
Target (mean)
37.64
Target (high)
52.00
Ratings (0m) 11 11 buy · 0 hold · 0 sell
  • Strong buy5
  • Buy6
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 11
  • 1 month ago 13
  • 2 months ago 13
  • 3 months ago 11

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

RGNX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.11-1.36 – -0.462-1.43+22.7%23.52M+5.9%8
Next quarter-1.17-1.35 – -1.04-1.34+12.4%19.93M+27.6%3
Current year-4.78-5.47 – -4.03-6.02+20.6%87.07M-3.5%9
Next year-0.8061-2.91 – 1.85-4.78+83.1%300.30M+244.9%9

Upgrades and downgrades

The latest rating changes

RGNX analyst upgrades and downgrades
DateFirmActionFromTo
Dec 11, 2024RBC CapitalReiteratedOutperformOutperform
Nov 21, 2024HC Wainwright & Co.MaintainedBuyBuy
Nov 20, 2024Chardan CapitalMaintainedBuyBuy
Nov 7, 2024HC Wainwright & Co.MaintainedBuyBuy
Oct 22, 2024Chardan CapitalMaintainedBuyBuy
Sep 4, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 5, 2024BarclaysMaintainedOverweightOverweight
Aug 5, 2024HC Wainwright & Co.MaintainedBuyBuy
Jun 20, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 7, 2024Goldman SachsInitiated—Buy
May 15, 2024HC Wainwright & Co.MaintainedBuyBuy
Apr 12, 2024StifelMaintainedBuyBuy
Mar 11, 2024HC Wainwright & Co.Initiated—Buy
Mar 8, 2024RBC CapitalUpgradeSector PerformOutperform
Mar 7, 2024Chardan CapitalMaintainedBuyBuy
Mar 7, 2024BarclaysMaintainedOverweightOverweight
Mar 6, 2024Leerink PartnersUpgradeMarket PerformOutperform
Mar 6, 2024BairdMaintainedOutperformOutperform
Feb 28, 2024WedbushReiteratedNeutralNeutral
Feb 12, 2024WedbushReiteratedNeutralNeutral
Nov 1, 2023StifelInitiated—Buy
Oct 5, 2023WedbushReiteratedNeutralNeutral
Oct 4, 2023RBC CapitalReiteratedSector PerformSector Perform
Aug 29, 2023Morgan StanleyMaintainedOverweightOverweight
Aug 3, 2023Chardan CapitalReiterated—Buy
Jul 12, 2023RBC CapitalReiteratedSector PerformSector Perform
Jun 20, 2023BairdInitiated—Outperform
Jun 2, 2023BairdInitiated—Outperform
May 9, 2023Morgan StanleyMaintained—Overweight
May 5, 2023Chardan CapitalMaintained—Buy